Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-Analysis from a Public Health Policy Perspective

Beck CR, McKenzie BC, Hashim AB, Harris RC, Zanuzdana A, Agboado G, Orton E, Béchard-Evans L, Morgan G, Stevenson C, Weston R, et al. (2011)
PLoS ONE 6(12): e29249.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ; ; ; ;
Alle
Erscheinungsjahr
Zeitschriftentitel
PLoS ONE
Band
6
Zeitschriftennummer
12
Seite
e29249
ISSN
eISSN
PUB-ID

Zitieren

Beck CR, McKenzie BC, Hashim AB, et al. Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-Analysis from a Public Health Policy Perspective. PLoS ONE. 2011;6(12):e29249.
Beck, C. R., McKenzie, B. C., Hashim, A. B., Harris, R. C., Zanuzdana, A., Agboado, G., Orton, E., et al. (2011). Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-Analysis from a Public Health Policy Perspective. PLoS ONE, 6(12), e29249. doi:10.1371/journal.pone.0029249
Beck, C. R., McKenzie, B. C., Hashim, A. B., Harris, R. C., Zanuzdana, A., Agboado, G., Orton, E., Béchard-Evans, L., Morgan, G., Stevenson, C., et al. (2011). Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-Analysis from a Public Health Policy Perspective. PLoS ONE 6, e29249.
Beck, C.R., et al., 2011. Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-Analysis from a Public Health Policy Perspective. PLoS ONE, 6(12), p e29249.
C.R. Beck, et al., “Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-Analysis from a Public Health Policy Perspective”, PLoS ONE, vol. 6, 2011, pp. e29249.
Beck, C.R., McKenzie, B.C., Hashim, A.B., Harris, R.C., Zanuzdana, A., Agboado, G., Orton, E., Béchard-Evans, L., Morgan, G., Stevenson, C., Weston, R., Mukaigawara, M., Enstone, J., Augustine, G., Butt, M., Kim, S., Puleston, R., Dabke, G., Howard, R., O'Boyle, J., O'Brien, M., Ahyow, L., Denness, H., Farmer, S., Figureroa, J., Fisher, P., Greaves, F., Haroon, M., Haroon, S., Hird, C., Isba, R., Ishola, D.A., Kerac, M., Parish, V., Roberts, J., Rosser, J., Theaker, S., Wallace, D., Wigglesworth, N., Lingard, L., Vinogradova, Y., Horiuchi, H., Peñalver, J., Nguyen-Van-Tam, J.S.: Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-Analysis from a Public Health Policy Perspective. PLoS ONE. 6, e29249 (2011).
Beck, Charles R., McKenzie, Bruce C., Hashim, Ahmed B., Harris, Rebecca C., Zanuzdana, Arina, Agboado, Gabriel, Orton, Elizabeth, Béchard-Evans, Laura, Morgan, Gemma, Stevenson, Charlotte, Weston, Rachel, Mukaigawara, Mitsuru, Enstone, Joanne, Augustine, Glenda, Butt, Mobasher, Kim, Sophie, Puleston, Richard, Dabke, Girija, Howard, Robert, O'Boyle, Julie, O'Brien, Mary, Ahyow, Lauren, Denness, Helene, Farmer, Siobhan, Figureroa, Jose, Fisher, Paul, Greaves, Felix, Haroon, Munib, Haroon, Sophie, Hird, Caroline, Isba, Rachel, Ishola, David A., Kerac, Marko, Parish, Vivienne, Roberts, Jonathan, Rosser, Julia, Theaker, Sarah, Wallace, Dean, Wigglesworth, Neil, Lingard, Liz, Vinogradova, Yana, Horiuchi, Hiroshi, Peñalver, Javier, and Nguyen-Van-Tam, Jonathan S. “Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-Analysis from a Public Health Policy Perspective”. PLoS ONE 6.12 (2011): e29249.

27 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial).
Tackenberg B, Schneider M, Blaes F, Eienbröker C, Schade-Brittinger C, Wellek A, Deschauer M, Eickmann M, Klenk HD, Müller HH, Sommer N., EBioMedicine 28(), 2018
PMID: 29337134
Altered immune cell follicular dynamics in HIV infection following influenza vaccination.
Moysi E, Pallikkuth S, De Armas LR, Gonzalez LE, Ambrozak D, George V, Huddleston D, Pahwa R, Koup RA, Petrovas C, Pahwa S., J Clin Invest 128(7), 2018
PMID: 29911996
Patterns of hospital admission in 54 501 patients with epistaxis over a 20-year period in Scotland, UK.
Douglas CM, Tikka T, Broadbent B, Calder N, Montgomery J., Clin Otolaryngol 43(6), 2018
PMID: 29953726
Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy.
Nakashima K, Aoshima M, Ohfuji S, Suzuki K, Katsurada M, Katsurada N, Misawa M, Otsuka Y, Kondo K, Hirota Y., Hum Vaccin Immunother 13(3), 2017
PMID: 27820665
Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis.
Domnich A, Arata L, Amicizia D, Puig-Barberà J, Gasparini R, Panatto D., Vaccine 35(4), 2017
PMID: 28024956
Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy.
Goswami M, Prince G, Biancotto A, Moir S, Kardava L, Santich BH, Cheung F, Kotliarov Y, Chen J, Shi R, Zhou H, Golding H, Manischewitz J, King L, Kunz LM, Noonan K, Borrello IM, Smith BD, Hourigan CS., J Transl Med 15(1), 2017
PMID: 28693586
Influenza vaccination status and outcomes among influenza-associated hospitalizations in Columbus, Ohio (2012-2015).
Zivich PN, Tatham L, Lung K, Tien J, Bollinger CE, Bower JK., Epidemiol Infect 145(15), 2017
PMID: 29032772
Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness.
Sullivan SG, Tchetgen Tchetgen EJ, Cowling BJ., Am J Epidemiol 184(5), 2016
PMID: 27587721
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.
Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR, Convalescent Plasma Study Group., J Infect Dis 211(1), 2015
PMID: 25030060
Healthcare workers' willingness to work during an influenza pandemic: a systematic review and meta-analysis.
Aoyagi Y, Beck CR, Dingwall R, Nguyen-Van-Tam JS., Influenza Other Respir Viruses 9(3), 2015
PMID: 25807865
Microbes and allogeneic transplantation.
Alegre ML, Bartman C, Chong AS., Transplantation 97(1), 2014
PMID: 23903013
Methodological quality of systematic reviews on influenza vaccination.
Remschmidt C, Wichmann O, Harder T., Vaccine 32(15), 2014
PMID: 24513008
Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists.
Germano V, Cattaruzza MS, Osborn J, Tarantino A, Di Rosa R, Salemi S, D'Amelio R., J Transl Med 12(), 2014
PMID: 24655394
Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients.
van der Velden MV, Geisberger A, Dvorak T, Portsmouth D, Fritz R, Crowe BA, Herr W, Distler E, Wagner EM, Zeitlinger M, Sauermann R, Stephan C, Ehrlich HJ, Barrett PN, Aichinger G., Clin Vaccine Immunol 21(6), 2014
PMID: 24739978
Protective immunity and safety of a genetically modified influenza virus vaccine.
Barbosa RP, Salgado AP, Garcia CC, Filho BG, Gonçalves AP, Lima BH, Lopes GA, Rachid MA, Peixoto AC, de Oliveira DB, Ataíde MA, Zirke CA, Cotrim TM, Costa ÉA, Almeida GM, Russo RC, Gazzinelli RT, Machado Ade M., PLoS One 9(6), 2014
PMID: 24927156
Influenza vaccination in HIV-positive subjects: latest evidence and future perspective.
Ceravolo A, Orsi A, Parodi V, Ansaldi F., J Prev Med Hyg 54(1), 2013
PMID: 24396998
Management of influenza infection in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI).
López-Medrano F, Cordero E, Gavaldá J, Cruzado JM, Marcos MÁ, Pérez-Romero P, Sabé N, Gómez-Bravo MÁ, Delgado JF, Cabral E, Carratalá J, Study Group of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases, Clinical Microbiology (SEIMC), Spanish Network for Research in Infectious Diseases (REIPI)., Enferm Infecc Microbiol Clin 31(8), 2013
PMID: 23528341
Does vaccine dose predict response to the monovalent pandemic H1N1 influenza a vaccine in children with acute lymphoblastic leukemia? A single-centre study.
Leahy TR, Smith OP, Bacon CL, Storey L, Lynam P, Gavin PJ, Butler KM, O'Marcaigh AS., Pediatr Blood Cancer 60(10), 2013
PMID: 23682005
Prevention of infection caused by immunosuppressive drugs in gastroenterology.
Orlicka K, Barnes E, Culver EL., Ther Adv Chronic Dis 4(4), 2013
PMID: 23819020
Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysis.
Beck CR, McKenzie BC, Hashim AB, Harris RC, Zanuzdana A, Agboado G, Orton E, Béchard-Evans L, Morgan G, Stevenson C, Weston R, Mukaigawara M, Enstone J, Augustine G, Butt M, Kim S, Puleston R, Dabke G, Howard R, O'Boyle J, O'Brien M, Ahyow L, Denness H, Farmer S, Figureroa J, Fisher P, Greaves F, Haroon M, Haroon S, Hird C, Isba R, Ishola DA, Kerac M, Parish V, Roberts J, Rosser J, Theaker S, Wallace D, Wigglesworth N, Lingard L, Vinogradova Y, Horiuchi H, Peñalver J, Nguyen-Van-Tam JS., Influenza Other Respir Viruses 7 Suppl 2(), 2013
PMID: 24034488
Immunogenicity of influenza vaccine in colorectal cancer patients.
Kim DH, Lee YY, Shin US, Moon SM., Cancer Res Treat 45(4), 2013
PMID: 24454003
Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology.
Beck CR, McKenzie BC, Hashim AB, Harris RC, University of Nottingham Influenza and the ImmunoCompromised (UNIIC) Study Group,, Nguyen-Van-Tam JS., J Infect Dis 206(8), 2012
PMID: 22904335
Immunogenicity and acceptance of influenza A (H1N1) vaccine in a cohort of chronic hepatitis C patients receiving pegylated-interferon treatment.
Hernández-Guerra M, González-Méndez Y, de Molina P, Gimeno-García AZ, Carrillo M, Casanova C, Pumarola T, Jimenez A, Hernández-Porto M, Torres A, Quintero E., PLoS One 7(11), 2012
PMID: 23144908
Influenza vaccination in solid-organ transplant recipients.
Cordero E, Manuel O., Curr Opin Organ Transplant 17(6), 2012
PMID: 23042206

258 References

Daten bereitgestellt von Europe PubMed Central.

Influenza-associated hospitalizations in the United States.
Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K., JAMA 292(11), 2004
PMID: 15367555
Mortality associated with influenza and respiratory syncytial virus in the United States.
Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K., JAMA 289(2), 2003
PMID: 12517228
Viral loads and duration of viral shedding in adult patients hospitalized with influenza.
Lee N, Chan PK, Hui DS, Rainer TH, Wong E, Choi KW, Lui GC, Wong BC, Wong RY, Lam WY, Chu IM, Lai RW, Cockram CS, Sung JJ., J. Infect. Dis. 200(4), 2009
PMID: 19591575
Duration of influenza A virus shedding in hospitalized patients and implications for infection control.
Leekha S, Zitterkopf NL, Espy MJ, Smith TF, Thompson RL, Sampathkumar P., Infect Control Hosp Epidemiol 28(9), 2007
PMID: 17932829
Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients.
Giannella M, Alonso M, Garcia D, Roa PL, Catalan P., 2010
Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT.
Mohty B, Thomas Y, Vukicevic M, Nagy M, Levrat E., 2011
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.
Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M; European Influenza Surveillance Scheme, Lachner P, Popow-Kraupp T, Strauss R, Brochier B, Sabbe M, Thomas I, Casteren V, Yane F, Georgieva T, Kojouharova M, Kotseva R, Kurchatova A, Aleraj B, Drazenovic V, Bagatzouni-Pieridou D, Elia A, Havlickova M, Kyncl J, Glismann S, Mazick A, Nielsen L, Fleming DM, Lackenby A, Watson J, Zambon M, Sadikova O, Sarv I, Ziegler T, Cohen JM, Enouf V, Lina B, Mosnier A, Valette M, van der Werf S, Buchholz U, Haas W, Schweiger B, Kossivakis AG, Kyriazopoulou-Dalaina V, Mentis A, Spala G, Berencsi G, Csohan A, Jankovics I, Coughlan S, Domegan L, Duffy M, Joyce M, O'Donnell J, O'Flanagan D, Ansaldi F, Crovari P, Donatelli I, Pregliasco F, Nikiforova R, Van Velicko I, Zamjatina N, Griskevicius A, Kupreviciene N, Rimseliene G, Mossong J, Opp M, Barbara C, Melillo T, Arkema A, Meerhoff T, Paget WJ, van der Velden K, Dijkstra F, Donker G, de Jong JC, Meijer A, Rimmelzwaan G, van der Sande M, Wilbrink B, Coyle P, Kennedy H, O'Neill H, Hungnes O, Iversen B, Brydak L, Romanowska M, Falcao IM, Falcao JM, Rebelo de Andrade H, Alexandrescu V, Lupulescu E, Carman W, Gunson R, Kean J, McMenamin J, Milic N, Nedeljkovic J, Blaskovicova H, Kristufkova Z, Slacikova M, Prosenc K, Socan M, Casas I, Larrrauri A, de Mateo S, Ortiz de Lejarazu R, Perez-Brena P, Pumarola Sune T, Vega Alonso T, Brytting M, Linde A, Penttinen P, Rubinova S, Thomas Y, Witschi M, Yilmaz N, Aranova M, Mironenko A, Hay A, Jones R, Thomas D., Emerging Infect. Dis. 15(4), 2009
PMID: 19331731
Influenza vaccination and chemotherapy: a shot in the dark?
Ring A, Marx G, Steer C, Harper P., Support Care Cancer 10(6), 2002
PMID: 12353124
Influenza vaccination in children being treated with chemotherapy for cancer.
Goossen GM, Kremer LC, van de Wetering MD., Cochrane Database Syst Rev (2), 2009
PMID: 19370636
Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis.
Anema A, Mills E, Montaner J, Brownstein JS, Cooper C., HIV Med. 9(1), 2008
PMID: 18199173
Chapter 19 Influenza (updated January 2011).
AUTHOR UNKNOWN, 2006
Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010.
Pebody RG, McLean E, Zhao H, Cleary P, Bracebridge S., 2010
Hospitalization in two waves of pandemic influenza A(H1N1) in England.
Campbell CN, Mytton OT, McLean EM, Rutter PD, Pebody RG., 2010
Mortality of 2009 pandemic influenza A(H1N1) in Germany.
Wilking H, Buda S, von E, Altmann D, Krause G., 2010
A nosocomial outbreak of 2009 pandemic influenza A(H1N1) in a paediatric oncology ward in Italy, October-November 2009.
Chironna M, Tafuri S, Santoro N, Prato R, Quarto M., 2010
Outbreak of novel influenza A (H1N1) in an adult haematology department and haematopoietic cell transplantation unit: clinical presentation and outcome.
Lalayanni C, Sirigou A, Iskas M, Smias C, Sakellari I, Anagnostopoulos A., J. Infect. 61(3), 2010
PMID: 20600296
Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010.
Enstone JE, Myles PR, Openshaw PJ, Gadd EM, Lim WS, Semple MG, Read RC, Taylor BL, McMenamin J, Armstrong C, Bannister B, Nicholson KG, Nguyen-Van-Tam JS., Emerging Infect. Dis. 17(4), 2011
PMID: 21470446
Clinical effectiveness of influenza vaccination for immunocompromised patients: a systematic review and meta-analysis.
Beck C, McKenzie B, Hashim A, Nguyen-Van-Tam J., 2011
WHO Guidelines for Pharmacological Management of Pandemic Influenza A(H1N1) 2009 and other Influenza Viruses. Part I Recommendations.
AUTHOR UNKNOWN, 2010

AUTHOR UNKNOWN, 1997
ICH Expert Working Group.
AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 2009
Systems to rate the strength of scientific evidence. Evidence report/technology appraisal number 47.
West S, King V, Carey T, Lohr K, McKoy N., 2002
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group, Altman D, Antes G, Atkins D, Barbour V, Barrowman N, Berlin JA, Clark J, Clarke M, Cook D, D'Amico R, Deeks JJ, Devereaux PJ, Dickersin K, Egger M, Ernst E, Gotzsche PC, Grimshaw J, Guyatt G, Higgins J, Ioannidis JP, Kleijnen J, Lang T, Liberati A, Magrini N, McNamee D, Moja L, Moher D, Mulrow C, Napoli M, Oxman A, Pham B, Rennie D, Sampson M, Schulz KF, Shekelle PG, Tetzlaff J, Tovey D, Tugwell P., BMJ 339(), 2009
PMID: 19622551

AUTHOR UNKNOWN, 2010
Vaccins: pour ou contre?
Delafond P., 1990
Le rôle des vaccinations dans la baisse de la mortalité.
Mesle F, Vallin J., 1999
Vacunación en el paciente con virus de inmunodeficiencia humana.
Pereira G, Tondo Á., 2009
Flu vaccine in patients with orthotopic heart transplantation.
Falchetti null, Magnani null., 2000
Immune response to influenza vaccine in patients with asthma - lack of effect of corticosteroid therapy.
Hanania NA, Sockrider M, Wise R, Castro M, Tonascia J., 2002
Influenza virus vaccination of patients with SLE: effects on generation of autoantibodies.
Abu-Shakra M, Press J, Sukenik S, Buskila D., Clin. Rheumatol. 21(5), 2002
PMID: 12223983
Antibody response to influenza immunization in patients after heart transplantation.
Admon D, Engelhard D, Strauss N, Goldman N, Zakay-Rones Z., Vaccine 15(14), 1997
PMID: 9330462
Reactogenicity and immunogenicity of bivalent influenza A and monovalent influenza B virus vaccines in high-risk children.
Allison JE, Glezen WP, Taber LH, Paredes A, Webster RG., J. Infect. Dis. 136 Suppl(), 1977
PMID: 606790
Early post-transplant vaccination with pandemic influenza A/H1N1 vaccine in pediatric heart transplant recipients.
Altamirano-Diaz L, West L, Humar A, Ely L, Urschel S, Gubbay J, Crowcroft N, Kumar D., Pediatr Transplant 15(2), 2010
PMID: 21176017
Influenza vaccination of HIV-1-positive and HIV-1-negative former intravenous drug users.
Amendola A, Boschini A, Colzani D, Anselmi G, Oltolina A, Zucconi R, Begnini M, Besana S, Tanzi E, Zanetti AR., J. Med. Virol. 65(4), 2001
PMID: 11745926
Seroconversion after influenza vaccination in patients with lung cancer.
Anderson H, Petrie K, Berrisford C, Charlett A, Thatcher N, Zambon M., Br. J. Cancer 80(1-2), 1999
PMID: 10389999
Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis.
Anema A, Mills E, Montaner J, Brownstein JS, Cooper C., HIV Med. 9(1), 2008
PMID: 18199173
Efficacy of influenza A(H1N1v) vaccination in children with cancer.
Antonio R, Delogu G, Sali M, Coccia P, Pierri F., 2010
Humoral and cellular responses to influenza vaccination in human recipients naturally tolerant to a kidney allograft.
Ballet C, Roussey-Kesler G, Aubin JT, Brouard S, Giral M, Miqueu P, Louis S, van der Werf S, Soulillou JP., Am. J. Transplant. 6(11), 2006
PMID: 17049065
Influenza vaccination of human immunodeficiency virus 1-infected patients receiving antiretroviral therapy.
Banic S, Koren S, Tomazic J, Vidmar L, Ihan A, Poljak M, Avsic-Zupanc A., Acta Virol. 45(1), 2001
PMID: 11394576
Immungenicity of novel influenza A (H1N1) vaccine in UK children with cancer: a single centre study.
Bate J, Yung C, Hoschler K, Sheasby L, Taj M., 2010
Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom.
Bate J, Yung CF, Hoschler K, Sheasby L, Morden J, Taj M, Heath PT, Miller E., Clin. Infect. Dis. 51(12), 2010
PMID: 21067352
Impaired humoral response to influenza vaccine and prolonged B memory cell depletion as a consequence of rituximab-based immunochemotherapy in non-hodgkin lymphoma patients.
Bedognetti D, Zoppoli G, Massucco C, Zupo S, Sertoli MR., 2009
Prolonged lack of humoral response to influenza vaccine associated with a persistent depletion of B memory cells in non hodgkin's lymphoma patients treated with rituximab-containing immunochemotherapy.
Bedognetti D, Zoppoli G, Zanardi E, Massucco C, Sertoli MR., 2010
Assessment of the immune response to trivalent split influenza vaccine in children with solid tumors.
Bektas O, Karadeniz C, Oguz A, Berberoglu S, Yilmaz N, Citak C., Pediatr Blood Cancer 49(7), 2007
PMID: 17262793
Risk factors for poor immune response to influenza vaccination in elderly people.
Bellei NC, Carraro E, Castelo A, Granato CF., Braz J Infect Dis 10(4), 2006
PMID: 17293910
Comparison of neutralizing and hemagglutination-inhibiting antibody responses to influenza A virus vaccination of human immunodeficiency virus-infected individuals.
Benne CA, Kroon FP, Harmsen M, Tavares L, Kraaijeveld CA, De Jong JC., Clin. Diagn. Lab. Immunol. 5(1), 1998
PMID: 9455891

Bergeron A., 2010
Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients.
Bickel M, Wieters I, Khaykin P, Nisius G, Haberl A, Stephan C, Von Hentig N, Herrmann E, Doerr HW, Brodt HR, Allwinn R., AIDS 24(9), 2010
PMID: 20559034
Humoral response to influenza hemagglutinin: oligoclonal spectrotype and failure of thymopentin as immunoadjuvant.
Biselli R, Fagiolo U, Nisini R, Paganelli R, D'Offizi G, Ferrara R, Bertollo L, D'Amelio R., Gerontology 41(1), 1995
PMID: 7737532
The immunogenicity of influenza virus vaccine in solid organ transplant recipients.
Blumberg EA, Albano C, Pruett T, Isaacs R, Fitzpatrick J, Bergin J, Crump C, Hayden FG., Clin. Infect. Dis. 22(2), 1996
PMID: 8838186
Safety of influenza vaccine in heart transplant recipients.
Blumberg EA, Fitzpatrick J, Stutman PC, Hayden FG, Brozena SC., J. Heart Lung Transplant. 17(11), 1998
PMID: 9855446
A single dose of an adjuvanted influenza A H1N1 vaccine (pandemrix (R)) does not provide a protective immune response in the majority of renal transplant recipients.
Brakemeier S, Schweiger B, Glander P, Diekmann F, Neuma-Yer HH., 2010
Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses.
Briggs WA, Rozek RJ, Migdal SD, Shillis JL, Brackett RG, Brandon FB, Mahajan SK, McDonald FD., Ann. Intern. Med. 92(4), 1980
PMID: 6987929
Immunization against influenza in children with cancer: results of a three-dose trial.
Brown AE, Steinherz PG, Miller DR, Armstrong D, Kellick MG, Gross PA, Davis AE., J. Infect. Dis. 145(1), 1982
PMID: 7054313
Immunologic response of immunosuppressed children to influenza vaccine.
Brunell PA., 1977
Immunogenicity of influenza vaccine in patients with hemato-oncological disorders.
Brydak LB, Calbecka M., Leuk. Lymphoma 32(3-4), 1999
PMID: 10037036
Humoral immune response after vaccination against influenza in patients with breast cancer.
Brydak LB, Guzy J, Starzyk J, Machala M, Gozdz SS., 2000
Humoral response to influenza vaccination in HIV-infected patients.
Brydak LB, Hryniewicz HJ, Machala M, Horban A., 1999
Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma.
Brydak LB, Machala M, Centkowski P, Warzocha K, Bilinski P., Vaccine 24(44-46), 2006
PMID: 16870313
Antibody response to influenza vaccination in splenectomized patients in Poland.
Brydak LB, Machala M, Laguna P, Rokicka-Milewska R., J. Clin. Immunol. 24(3), 2004
PMID: 15114053
Studies on the humoral immune response to hemagglutinin of influenza vaccine in children with acute lymphoblastic leukemia after chemotherapy treatment.
Brydak LB, Rokicka-Milewska R, Machala M, Jackowska T., 2000
Immunogenicity of subunit trivalent influenza vaccine in children with acute lymphoblastic leukemia.
Brydak LB, Rokicka-Milewska R, Machala M, Jackowska T, Sikorska-Fic B., Pediatr. Infect. Dis. J. 17(2), 1998
PMID: 9493808
Immunological response to influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients.
Bucalossi A, Marotta G, Galieni P, Bigazzi C, Valenzin PE, Dispensa E., Acta Haematol. 93(1), 1995
PMID: 7725854
Influenza vaccination in liver transplant recipients.
Burbach G, Bienzle U, Stark K, Rayes N, Neuhaus R, Serke S, Engelmann H, Kunzel W, Turk G, Neuhaus P., Transplantation 67(5), 1999
PMID: 10096534
Humoral and Cellular Immune Responses after Influenza Vaccination in Kidney Transplant Recipients.
Candon S, Thervet E, Lebon P, Suberbielle C, Lima C., 2009
Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients.
Candon S, Thervet E, Lebon P, Suberbielle C, Zuber J, Lima C, Charron D, Legendre C, Chatenoud L., Am. J. Transplant. 9(10), 2009
PMID: 19656126
Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients.
Canestri A, Krivine A, Assoumou L, Le Corre M, Rozenberg F, Marcelin AG, Schneider L, Samri A, Carcelain G, Autran B, Katlama C, Guihot A., AIDS 24(18), 2010
PMID: 20962616
Response to influenza vaccine by renal transplant patients.
Carroll RN, Marsh SD, O'Donoghue EP, Breeze DC, Shackman R., Br Med J 2(5921), 1974
PMID: 4605057
The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.
Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T., Scand. J. Urol. Nephrol. 37(1), 2003
PMID: 12745749
Immunogenicity of influenza vaccination in patients with non-Hodgkin lymphoma.
Centkowski P, Brydak L, Machala M, Kalinka-Warzocha E, Blasinska-Morawiec M, Federowicz I, Walewski J, Wegrzyn J, Wolowiec D, Lech-Maranda E, Sawczuk-Chabin J, Bilinski P, Warzocha K; Polish Lymphoma Research Group., J. Clin. Immunol. 27(3), 2007
PMID: 17345151
Effect of 25 hydroxy vitamin D status on serological response to influenza vaccine in cancer patients.
Chadha MK, Fakih MG, Tian L, Mashtare T, Nesline M., 2009
Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children.
Chadwick EG, Chang G, Decker MD, Yogev R, Dimichele D, Edwards KM., Pediatr. Infect. Dis. J. 13(3), 1994
PMID: 8177629
Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity.
Chalmers A, Scheifele D, Patterson C, Williams D, Weber J, Shuckett R, Teufel A., J. Rheumatol. 21(7), 1994
PMID: 7966058
Clinical effectiveness of prevention of influenza and ARVI among children living in ecologically disadvantaged regions.
Chebotareva TA, Mazankova LN, Malinovskaya VV, Kariaeva SK, Lazarev VV., 2009
Influenza immunisation in children with solid tumours.
Chisholm J, Howe K, Taj M, Zambon M., Eur. J. Cancer 41(15), 2005
PMID: 16143516
Response to influenza immunisation during treatment for cancer.
Chisholm JC, Devine T, Charlett A, Pinkerton CR, Zambon M., Arch. Dis. Child. 84(6), 2001
PMID: 11369567
Effects of influenza immunization on humoral and cellular alloreactivity in humans.
Danziger-Isakov L, Cherkassky L, Siegel H, McManamon M, Kramer K, Budev M, Sawinski D, Augustine JJ, Hricik DE, Fairchild R, Heeger PS, Poggio ED., Transplantation 89(7), 2010
PMID: 20179666
Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host.
de Lavallade H, Garland P, Sekine T, Hoschler K, Marin D, Stringaris K, Loucaides E, Howe K, Szydlo R, Kanfer E, Macdonald D, Kelleher P, Cooper N, Khoder A, Gabriel IH, Milojkovic D, Pavlu J, Goldman JM, Apperley JF, Rezvani K., Haematologica 96(2), 2010
PMID: 20971824
Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients.
de Roux A, Marx A, Burkhardt O, Schweiger B, Borkowski A, Banzhoff A, Pletz MW, Lode H., Vaccine 24(10), 2005
PMID: 16288937

DeBruyn JCC., 2010
Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
Del Porto F, Lagana B, Biselli R, Donatelli I, Campitelli L, Nisini R, Cardelli P, Rossi F, D'Amelio R., Vaccine 24(16), 2006
PMID: 16466833
Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation.
Dengler TJ, Strnad N, Buhring I, Zimmermann R, Girgsdies O, Kubler WE, Zielen S., Transplantation 66(10), 1998
PMID: 9846520
Effect of annual influenza immunization on antibody response in lung transplant patients.
Dopp JM, Wiegert NA, Moran JJ, Francois ML, Radford KL, Thomas H, Love RB, Hayney MS., Prog Transplant 19(2), 2009
PMID: 19588665
Immune response to influenza vaccine in adult liver transplant recipients.
Duchini A, Hendry RM, Nyberg LM, Viernes ME, Pockros PJ., Liver Transpl. 7(4), 2001
PMID: 11303290
Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults.
Durando P, Fenoglio D, Boschini A, Ansaldi F, Icardi G, Sticchi L, Renzoni A, Fabbri P, Ferrera A, Parodi A, Bruzzone B, Gabutti G, Podda A, Del Giudice G, Fragapane E, Indiveri F, Crovari P, Gasparini R., Clin. Vaccine Immunol. 15(2), 2007
PMID: 18003811
Effective immunization against influenza in pediatric renal transplant recipients.
Edvardsson VO, Flynn JT, Deforest A, Kaiser BA, Schulman SL, Bradley A, Palmer J, Polinsky MS, Baluarte HJ., Clin Transplant 10(6 Pt 1), 1996
PMID: 8996778
Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients.
Engelhard D, Nagler A, Hardan I, Morag A, Aker M, Baciu H, Strauss N, Parag G, Naparstek E, Ravid Z., Bone Marrow Transplant. 11(1), 1993
PMID: 8431706
Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy.
Esposito S, Cecinati V, Scicchitano B, Delvecchio GC, Santoro N, Amato D, Pelucchi C, Jankovic M, De Mattia D, Principi N., Vaccine 28(6), 2009
PMID: 20003924
Immunization with influenza vaccine in patients with haematological malignant disease.
Feery BJ, Sullivan JR, Hurley TH, Evered MG., Med. J. Aust. 1(9), 1977
PMID: 859489
Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers.
Fomin I, Caspi D, Levy V, Varsano N, Shalev Y, Paran D, Levartovsky D, Litinsky I, Kaufman I, Wigler I, Mendelson E, Elkayam O., Ann. Rheum. Dis. 65(2), 2005
PMID: 16014674
Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients.
Fowke KR, D'Amico R, Chernoff DN, Pottage JC Jr, Benson CA, Sha BE, Kessler HA, Landay AL, Shearer GM., AIDS 11(8), 1997
PMID: 9223736
Influenza vaccination in heart transplant recipients.
Fraund S, Wagner D, Pethig K, Drescher J, Girgsdies OE, Haverich A., J. Heart Lung Transplant. 18(3), 1999
PMID: 10328147
Immune response to influenza vaccination in children with renal disease.
Furth SL, Neu AM, McColley SA, Case B, Steinhoff M, Fivush B., Pediatr. Nephrol. 9(5), 1995
PMID: 8580011
The influence of immunosuppressive therapy and underlying diseases on vaccine responses to influenza A H1N1/09 vaccines in inflammatory rheumatic diseases.
Gabay C, Meier S, Gascon D, Posfay-Barbe K, Combescure C., 2010
Responses of patients with neoplastic diseases to influenza virus vaccine.
Ganz PA, Shanley JD, Cherry JD., Cancer 42(5), 1978
PMID: 719604
Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab.
Gelinck LB, Teng YK, Rimmelzwaan GF, van den Bemt BJ, Kroon FP, van Laar JM., Ann. Rheum. Dis. 66(10), 2007
PMID: 17881666
The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination.
Gelinck LB, van der Bijl AE, Beyer WE, Visser LG, Huizinga TW, van Hogezand RA, Rimmelzwaan GF, Kroon FP., Ann. Rheum. Dis. 67(5), 2007
PMID: 17965123
The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study.
Glesby MJ, Hoover DR, Farzadegan H, Margolick JB, Saah AJ., J. Infect. Dis. 174(6), 1996
PMID: 8940228
Influenza vaccination on renal transplant patients is safe and serologically effective.
Grekas D, Alivanis P, Kiriazopoulou V, Dioudis C, Sioulis A, Derveniotis V, Tourkantonis A., Int J Clin Pharmacol Ther Toxicol 31(11), 1993
PMID: 8294168
Influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients.
Gribabis DA, Panayiotidis P, Boussiotis VA, Hannoun C, Pangalis GA., Acta Haematol. 91(3), 1994
PMID: 8091931
Influenza immunization in immunosuppressed children.
Gross PA, Lee H, Wolff JA, Hall CB, Minnefore AB, Lazicki ME., J. Pediatr. 92(1), 1978
PMID: 619076
Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.
Gunthard HF, Wong JK, Spina CA, Ignacio C, Kwok S, Christopherson C, Hwang J, Haubrich R, Havlir D, Richman DD., J. Infect. Dis. 181(2), 2000
PMID: 10669335
Adverse reactions of trivalent influenza vaccine in HIV-infected individuals.
Hajiabdolbaghi M, Jam S, SeyedAlinaghi S, Jafari S, Badie BM, Sabzvari D., Acta Med Iran 48(2), 2010
PMID: 21133001
Safety of live attenuated of live attenuated influenza vaccine in mild to moderately immunocompromised children with children.
Halasa N, Englund J, Nachman S, Weinberg G, Huber V., 2009
Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy.
Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, Atmar RL; American Lung Association Asthma Clinical Research Centers., J. Allergy Clin. Immunol. 113(4), 2004
PMID: 15100679
Lung transplant patients' T cell responses to influenza vaccine viruses between seasons.
Hayney MS, Moran J, Wiegert NA, Burlingham WJ., Vaccine 26(21), 2008
PMID: 18420314
Influenza vaccine antibody responses in lung transplant recipients.
Hayney MS, Welter DL, Francois M, Reynolds AM, Love RB., Prog Transplant 14(4), 2004
PMID: 15663020
Response to influenza A vaccine among high-risk patients.
Hodges GR, Davis JW, Lewis HD Jr, Whittier FC Jr, Siegel CD, Chin TD, Clark GM, Noble GR., South. Med. J. 72(1), 1979
PMID: 366766
Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M., Rheumatology (Oxford) 48(10), 2009
PMID: 19692457
Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M., Arthritis Rheum. 60(8), 2009
PMID: 19644961
Response to influenza vaccine in children with leukemia undergoing chemotherapy.
Hsieh YC, Lu MY, Kao CL, Chiang BL, Lin DT, Lin KS, Huang LM., J. Formos. Med. Assoc. 101(10), 2002
PMID: 12517044
Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men.
Huang KL, Ruben FL, Rinaldo CR Jr, Kingsley L, Lyter DW, Ho M., JAMA 257(15), 1987
PMID: 3560380
Response to influenza immunisation in asymptomatic HIV infected men.
Huengsberg M, Chakraverty MP, Cooper G, Shahmanesh M., Genitourin Med 71(6), 1995
PMID: 8566972
The response in hemagglutinoinhibiting antibodies following influenza vaccination of HIV-infected children.
Ionita E, Gherghina I, Lupulescu E, Alexandrescu V, Tabra ME., Roum Arch Microbiol Immunol 57(1), 1998
PMID: 9745335
Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users.
Iorio AM, Alatri A, Francisci D, Preziosi R, Neri M, Donatelli I, Castrucci MR, Biasio LR, Tascini C, Iapoce R, Pierucci P, Baldelli F., Vaccine 15(1), 1997
PMID: 9041673
Mycophenolate mofetil suppresses the humoral response to influenza vaccination in renal transplant recipients [abstract].
Isbel NM, Smith KGC, Leydon JA, Walker RG, Becker GJ., 1997
Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.
Issa NC, Marty FM, Gagne LS, Koo S, Verrill KA, Alyea EP, Cutler CS, Koreth J, Armand P, Ho VT, Antin JH, Soiffer RJ, Baden LR., Biol. Blood Marrow Transplant. 17(3), 2010
PMID: 20950701
Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy.
Kanakoudi-Tsakalidou F, Trachana M, Pratsidou-Gertsi P, Tsitsami E, Kyriazopoulou-Dalaina V., Clin. Exp. Rheumatol. 19(5), 2001
PMID: 11579723
Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial.
Keshtkar-Jahromi M, Argani H, Rahnavardi M, Mirchi E, Atabak S, Tara SA, Gachkar L, Noori-Froothghe A, Mokhtari-Azad T., Am. J. Nephrol. 28(4), 2008
PMID: 18322360
Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients.
Kimball P, Verbeke S, Flattery M, Rhodes C, Tolman D., Transplantation 69(11), 2000
PMID: 10868658
Influenza vaccination among heart transplant recipients.
Kimball P, Verbeke S, Tolman D., Transplant. Proc. 33(1-2), 2001
PMID: 11267511
Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.
King JC Jr, Fast PE, Zangwill KM, Weinberg GA, Wolff M, Yan L, Newman F, Belshe RB, Kovacs A, Deville JG, Jelonek M; HIV Influenza Study Group., Pediatr. Infect. Dis. J. 20(12), 2001
PMID: 11740317
Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.
King JC Jr, Treanor J, Fast PE, Wolff M, Yan L, Iacuzio D, Readmond B, O'Brien D, Mallon K, Highsmith WE, Lambert JS, Belshe RB., J. Infect. Dis. 181(2), 2000
PMID: 10669363
The response to vaccination against influenza in the season 1991/92 in HIV-1 infected persons.
Knysz B, Brydak LB, Inglot M, Gladysz A., 2001
Serological response to influenza vaccine in HIV-infected children in orphanages.
Kosalaraksa P, Srirompotong U, Newman R, Lumbiganon P, Wood JM., 0
Experience in administration of the vaccines “Pneumo 23” and “VAXIGRIP” among children at risk infected with Mycobacterium tuberculosis.
Kostyanaya IE, Meisner AF, Aksenova VA, Baturo AP., 2002
Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy.
Kroon FP, Rimmelzwaan GF, Roos MT, Osterhaus AD, Hamann D, Miedema F, van Dissel JT., AIDS 12(17), 1998
PMID: 9863863
Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study.
Kroon FP, van Dissel JT, de Jong JC, Zwinderman K, van Furth R., Vaccine 18(26), 2000
PMID: 10825608
Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroids.
Kubiet MA, Gonzalez-Rothi RJ, Cottey R, Bender BS., Chest 110(2), 1996
PMID: 8697835
Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis.
Kubota T, Nii T, Nanki T, Kohsaka H, Harigai M, Komano Y, Sugihara T, Nonomura Y, Hirose W, Nagasaka K, Sakurai T, Miyasaka N., Mod Rheumatol 17(6), 2007
PMID: 18084712
Efficacy of influenza vaccination in children with renal diseases undergone immunosuppressive therapy.
Kudo M, Onuma S, Kamio T, Endo Y, Tanaka H., 2005
Donor screening for human T-cell lymphotrophic virus 1/2: changing paradigms for changing testing capacity.
Kaul DR, Taranto S, Alexander C, Covington S, Marvin M, Nowicki M, Orlowski J, Pancoska C, Pruett TL, Ison MG; HTLV Donor Screening Advisory Group, Kaul D, Alexander C, Brubaker S, Covington S, Eisenbrey B, Ellison MD, Hull D, Hasz R, Higgins B, Ison M, Jaramillo A, Johnson McGaw L, Levi M, Marvin M, Mathieson M, Metzger B, Nowicki M, Orlowski J, Pancoska C, Pruett TL, Snydman D, Taranto S, Wright C, Wynn J., Am. J. Transplant. 10(2), 2009
PMID: 19839982
Donor screening for human T-cell lymphotrophic virus 1/2: changing paradigms for changing testing capacity.
Kaul DR, Taranto S, Alexander C, Covington S, Marvin M, Nowicki M, Orlowski J, Pancoska C, Pruett TL, Ison MG; HTLV Donor Screening Advisory Group, Kaul D, Alexander C, Brubaker S, Covington S, Eisenbrey B, Ellison MD, Hull D, Hasz R, Higgins B, Ison M, Jaramillo A, Johnson McGaw L, Levi M, Marvin M, Mathieson M, Metzger B, Nowicki M, Orlowski J, Pancoska C, Pruett TL, Snydman D, Taranto S, Wright C, Wynn J., Am. J. Transplant. 10(2), 2009
PMID: 19839982
Influenza vaccination in renal transplant recipients.
Kumar SS, Ventura AK, VanderWerf B., JAMA 239(9), 1978
PMID: 342736
Antibody responses to influenza immunization of children with acute lymphoblastic leukemia.
Lange B, Shapiro SA, Waldman MT, Proctor E, Arbeter A., J. Infect. Dis. 140(3), 1979
PMID: 291662
Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation.
Lawal A, Basler C, Branch A, Gutierrez J, Schwartz M, Schiano TD., Am. J. Transplant. 4(11), 2004
PMID: 15476480
Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy.
Lo W, Whimbey E, Elting L, Couch R, Cabanillas F, Bodey G., Eur. J. Clin. Microbiol. Infect. Dis. 12(10), 1993
PMID: 8307050
Clinical and antibody responses after influenza immunization in systemic lupus erythematosus.
Louie JS, Nies KM, Shoji KT, Fraback RC, Abrass C, Border W, Cherry JD, Imagawa D., Ann. Intern. Med. 88(6), 1978
PMID: 307356
A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.
Lu CC, Wang YC, Lai JH, Lee TS, Lin HT, Chang DM., Vaccine 29(3), 2010
PMID: 21078406
Immune response to influenza vaccine in children with inflammatory bowel disease.
Lu Y, Jacobson DL, Ashworth LA, Grand RJ, Meyer AL, McNeal MM, Gregas MC, Burchett SK, Bousvaros A., Am. J. Gastroenterol. 104(2), 2009
PMID: 19174786
Response to influenza virus vaccination in vertical HIV infection.
Lyall EG, Charlett A, Watkins P, Zambon M., Arch. Dis. Child. 76(3), 1997
PMID: 9135261
HIV-1 plasma viremia not increased in patients receiving highly active antiretroviral therapy after influenza vaccination.
Macias J, Pineda JA, Leal M, Abad MA, Delgado J, Rosa R, Rubio A, Sanchez-Quijano A, Lissen E., Eur. J. Clin. Microbiol. Infect. Dis. 20(1), 2001
PMID: 11245323
A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings.
Madan RP, Tan M, Fernandez-Sesma A, Moran TM, Emre S, Campbell A, Herold BC., Clin. Infect. Dis. 46(5), 2008
PMID: 18230041
Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study.
Magnani G, Falchetti E, Pollini G, Reggiani LB, Grigioni F, Coccolo F, Potena L, Magelli C, Sambri V, Branzi A., J. Heart Lung Transplant. 24(5), 2005
PMID: 15896757
Compromised B cell responses to influenza vaccination in HIV-infected individuals.
Malaspina A, Moir S, Orsega SM, Vasquez J, Miller NJ, Donoghue ET, Kottilil S, Gezmu M, Follmann D, Vodeiko GM, Levandowski RA, Mican JM, Fauci AS., J. Infect. Dis. 191(9), 2005
PMID: 15809902
Influenza immunization in children with chronic arthritis: a prospective study.
Malleson PN, Tekano JL, Scheifele DW, Weber JM., J. Rheumatol. 20(10), 1993
PMID: 7848389
Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.
Mamula P, Markowitz JE, Piccoli DA, Klimov A, Cohen L, Baldassano RN., Clin. Gastroenterol. Hepatol. 5(7), 2007
PMID: 17544875
Influenza vaccination in HIV-infected children.
Marczynska M, Brydak LB, Machala M, Oldakowska A, Zegadlo M., Acta Paediatr. 90(4), 2001
PMID: 11332945
Immune response after influenza vaccination in children with cancer.
Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T., Pediatr Blood Cancer 45(6), 2005
PMID: 16007602
Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus.
Mauch TJ, Crouch NA, Freese DK, Braunlin EA, Dunn DL, Kashtan CE., J. Pediatr. 127(6), 1995
PMID: 8523197
Efficacy of the influenza vaccine in patients with malignant lymphoma.
Mazza JJ, Yale SH, Arrowood JR, Reynolds CE, Glurich I, Chyou PH, Linneman JG, Reed KD., Clin Med Res 3(4), 2005
PMID: 16303886
The humoral immune response to influenza vaccination in lung transplant patients.
Mazzone PJ, Mossad SB, Mawhorter SD, Mehta AC, Schilz RJ, Maurer JR., Eur. Respir. J. 18(6), 2001
PMID: 11829104
Influenza vaccination of patients with systemic lupus erythematosus.
Mercado U, Acosta H, Avendano L., Rev. Invest. Clin. 56(1), 2004
PMID: 15144037
Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.
Meyer S, Adam M, Ilchmann C, Eulenburg C, Sattinger E., 2010
The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine.
Miotti PG, Nelson KE, Dallabetta GA, Farzadegan H, Margolick J, Clements ML., JAMA 262(6), 1989
PMID: 2787416
Efficacy and side effects of influenza vaccine for patients with pediatric rheumatic diseases under steroid and/or immunosuppressive therapy.
Miyamae T, Iwata N, Imagawa T, Mori M, Mitsuda T., 2002
Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.
Montoya CJ, Toro MF, Aguirre C, Bustamante A, Hernandez M, Arango LP, Echeverry M, Arango AE, Prada MC, Alarcon Hdel P, Rojas M., Mem. Inst. Oswaldo Cruz 102(4), 2007
PMID: 17612772
Immunological response to influenza vaccine in cancer patients undergoing treatment with sunitinib or sorafenib.
Mulder SF, Jacobs JFM, Olde MAM, Kremer IK, Mulders PFA., 2009
Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study.
Nailescu C, Xu X, Zhou H, Hall H, Wilson AC, Leiser JD, Chand DH, Valentini RP, Hebert D, Mahan JD., Pediatr. Nephrol. 26(3), 2010
PMID: 21181206
The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines.
Nelson KE, Clements ML, Miotti P, Cohn S, Polk BF., Ann. Intern. Med. 109(5), 1988
PMID: 2970238
Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma.
Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH, Wiselka MJ, Leese J, Ayres J, Campbell JH, Ebden P, Eiser NM, Hutchcroft BJ, Pearson JC, Willey RF, Wolstenholme RJ, Woodhead MA., Lancet 351(9099), 1998
PMID: 9652613
Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae.
Nordoy T, Aaberge IS, Husebekk A, Samdal HH, Steinert S, Melby H, Kolstad A., Med. Oncol. 19(2), 2002
PMID: 12180483
Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination.
O'Brien WA, Grovit-Ferbas K, Namazi A, Ovcak-Derzic S, Wang HJ, Park J, Yeramian C, Mao SH, Zack JA., Blood 86(3), 1995
PMID: 7620162
Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, Wigler I, Balbir-Gurman A, Caspi D, Elkayam O., Ann. Rheum. Dis. 67(7), 2007
PMID: 17981914
Pandemic influenza vaccine in adult HIV-1-infected patients.
Orlando G, Pariani E, Mazza F, Tanzi E, Meraviglia P, Gianelli E, Argenteri B, Amendola A, Galli M, Rizzardini G, Zanetti A., AIDS 24(13), 2010
PMID: 20679764
Influenza immunization of adult patients with malignant diseases.
Ortbals DW, Liebhaber H, Presant CA, Van Amburg AL 3rd, Lee JY., Ann. Intern. Med. 87(5), 1977
PMID: 921082
Antibody response to influenza vaccination in renal transplant patients: correlation with allograft function.
Pabico RC, Douglas RG, Betts RF, McKenna BA, Freeman RB., Ann. Intern. Med. 85(4), 1976
PMID: 788581
Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy.
Park CL, Frank AL, Sullivan M, Jindal P, Baxter BD., Pediatrics 98(2 Pt 1), 1996
PMID: 8692617
Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects.
Pinto LA, Blazevic V, Anderson SA, Venzon DJ, Trubey CM, Rowe T, Katz JM, Liewehr D, Dolan MJ, Shearer GM., J. Infect. Dis. 183(7), 2001
PMID: 11237823
Evaluation of Safety and Efficacy of H1N1 Swine-Origin Influenza A Vaccination in Renal Transplant Patients.
Rambal V, Mueller K, Nickel P, Horstrup J, Friedrich P., 2010
T cell activation and human immunodeficiency virus replication after influenza immunization of infected children.
Ramilo O, Hicks PJ, Borvak J, Gross LM, Zhong D, Squires JE, Vitetta ES., Pediatr. Infect. Dis. J. 15(3), 1996
PMID: 8852906
Impact of influenza vaccine on response to vaccination with pneumococcal vaccine in HIV patients.
Ranieri R, Veronelli A, Santambrogio C, Pontiroli AE., AIDS Res. Hum. Retroviruses 21(5), 2005
PMID: 15929703
Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma.
Rapezzi D, Sticchi L, Racchi O, Mangerini R, Ferraris AM, Gaetani GF., Eur. J. Haematol. 70(4), 2003
PMID: 12656745
Influenza vaccination has no effect on viral load in HIV-infected patients with higher CD4 counts.
Reboli AC, Palmer A, Byrne B, McCoy P, Chernoff D., 1996
A double-blind placebo-controlled study of the effect of influenza vaccination on airway responsiveness in asthma.
Reid DW, Bromly CL, Stenton SC, Hendrick DJ, Bourke SJ., Respir Med 92(8), 1998
PMID: 9893767
The efficacy of influenza vaccination in a pediatric oncology population.
Reilly A, Kersun LS, McDonald K, Weinberg A, Jawad AF, Sullivan KE., J. Pediatr. Hematol. Oncol. 32(5), 2010
PMID: 20485201
Influenza vaccination of patients with systemic lupus erythematosus.
Ristow SC, Douglas RG Jr, Condemi JJ., Ann. Intern. Med. 88(6), 1978
PMID: 666135
Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma.
Robertson JD, Nagesh K, Jowitt SN, Dougal M, Anderson H, Mutton K, Zambon M, Scarffe JH., Br. J. Cancer 82(7), 2000
PMID: 10755398
Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals.
Rosok B, Voltersvik P, Bjerknes R, Axelsson M, Haaheim LR, Asjo B., Clin. Exp. Immunol. 104(2), 1996
PMID: 8625509
Effect of influenza virus vaccine on the expression of human immunodeficiency virus co-receptor CCR5.
Rucker RP, Day NK, Good RA, Kamchaisatian W, Emmanuel P, Sleasman JW, Mayeski C, Dinglasan E, Haraguchi S, Tangsinmankong N., Ann. Allergy Asthma Immunol. 93(3), 2004
PMID: 15478388
Humoral and cell mediated immune response to bivalent influenza A/NJ/76 and A/Vict/75 vaccine in renal allograft recipients.
Rytel MW, Niebojewski RA, Rosenkranz MA, Sedmak G., Dev. Biol. Stand. 39(), 1977
PMID: 342308
Influenza vaccine response in HIV patients.
Salassa B, Zucco S, Macor A, Sciullo D, Ruffatto R., 1996
Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity.
Salemi S, Picchianti-Diamanti A, Germano V, Donatelli I, Di Martino A, Facchini M, Nisini R, Biselli R, Ferlito C, Podesta E, Cappella A, Milanetti F, Rossi F, Amodeo R, Tabacco F, Di Rosa R, Lagana B, D Amelio R., Clin. Immunol. 134(2), 2009
PMID: 19846344
Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine.
Sanchez-Fructuoso AI, Prats D, Naranjo P, Fernandez-Perez C, Gonzalez MJ, Mariano A, Gonzalez J, Figueredo MA, Martin JM, Paniagua V, Fereres J, Gomez de la Concha E, Barrientos A., Transplantation 69(3), 2000
PMID: 10706057
The influence of chemotherapy on response of patients with hematologic malignancies to influenza vaccine.
Schafer AI, Churchill WH, Ames P, Weinstein L., Cancer 43(1), 1979
PMID: 761165
Influenza vaccination is efficacious and safe in renal transplant recipients.
Scharpe J, Evenepoel P, Maes B, Bammens B, Claes K, Osterhaus AD, Vanrenterghem Y, Peetermans WE., Am. J. Transplant. 8(2), 2007
PMID: 18162092
Antibody response to tetravalent influenza subunit vaccine in patients infected with human immunodeficiency virus type 1.
Schneider MM, Sprenger MJ, Hoepelman IM, van der Graaf Y, Borleffs JC., Int. J. Antimicrob. Agents 6(4), 1996
PMID: 18611709
Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy.
Shahgholi E, Ehsani MA, Salamati P, Maysamie A, Sotoudeh K, Mokhtariazad T., Pediatr Blood Cancer 54(5), 2010
PMID: 20205258
Antibody response to influenza immunization in adult patients with malignant disease.
Shildt RA, Luedke DW, Kasai G, El-Beheri S, Laham MN., Cancer 44(5), 1979
PMID: 498034
Efficacy of influenza vaccination in adult liver transplant recipients.
Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ, Beyer WE, Tilanus HW, Kemmeren MH, Metselaar HJ, de Man RA, Osterhaus AD., J. Med. Virol. 61(1), 2000
PMID: 10745238
Influence of vaccination and surgery on HLA-DR expression in patients with upper aerodigestive tract cancer.
Spies CD, Kip M, Lau A, Sander M, Breuer JP, Meyerhoefer J, Paschen C, Schumacher G, Volk HD, Wernecke KD, von Dossow V., J. Int. Med. Res. 36(2), 2008
PMID: 18380940
Activation of virus replication after vaccination of HIV-1-infected individuals.
Staprans SI, Hamilton BL, Follansbee SE, Elbeik T, Barbosa P, Grant RM, Feinberg MB., J. Exp. Med. 182(6), 1995
PMID: 7500017
Influenza immunization of children with neoplastic diseases.
Steinherz PG, Brown AE, Gross PA, Braun D, Ghavimi F, Wollner N, Rosen G, Armstrong D, Miller DR., Cancer 45(4), 1980
PMID: 7357492
Impaired serum antibody response to inactivated influenza A and B vaccine in renal transplant recipients.
Stiver HG, Graves P, Meiklejohn G, Schroter G, Eickhoff TC., Infect. Immun. 16(3), 1977
PMID: 330394
Bivalent influenza vaccine in children with cancer.
Sumaya CV, Williams TE, Brunell PA., J. Infect. Dis. 136 Suppl(), 1977
PMID: 606789
Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy.
Tanzi E, Esposito S, Bojanin J, Amendola A, Trabattoni D, Pariani E, Pinzani R, Zanetti A, Principi N., J. Med. Virol. 78(4), 2006
PMID: 16482542
Effectiveness of influenza vaccination of children with rheumatic diseases.
Tarasova AA., 2006
Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial.
Tasker SA, O'Brien WA, Treanor JJ, Weiss PJ, Olson PE, Kaplan AH, Wallace MR., Vaccine 16(9-10), 1998
PMID: 9682356
Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial.
Tasker SA, Treanor JJ, Paxton WB, Wallace MR., Ann. Intern. Med. 131(6), 1999
PMID: 10498559
Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals.
Tebas P, Frank I, Lewis M, Quinn J, Zifchak L, Thomas A, Kenney T, Kappes R, Wagner W, Maffei K, Sullivan K; Center for AIDS Research and Clinical Trials Unit of the University of Pennsylvania., AIDS 24(14), 2010
PMID: 20616698
Safety and efficacy of an inactivated, unadjuvanted vaccine adainst the novel influenza A variant (H1N1v) in renal transplant recipients (transfluvac study).
Thibault F, Noble CP, Morelon E, Daoud S, Cahen R., 2010
Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients.
Tremblay CL, Rouleau D, Fortin C, Toma E, Sylla M, Cyr L, Cote S, Baz M, Sampalis J, Trautman L, Sekaly RP, Boivin G., Vaccine 29(7), 2010
PMID: 21185423
Immune response against influenza vaccination in patients with rheumatoid arthritis undergoing IL-6 inhibition therapy (tocilizumab) compared with DMARDs.
Tsuru T, Suzaki M, Yoshio N, Mima T, Nakashima H., 2008
Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, Blom M, Risselada AP, de Haan A, Westra J, Kallenberg CG, Bijl M., Arthritis Rheum. 62(1), 2010
PMID: 20039396
Serological responses after vaccination for influenza in patients with primary humoral immunodeficiency.
van S, Holvast A, Telgt DS, Benne CA, de A., 2008
Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine.
van Assen S, Holvast A, Telgt DS, Benne CA, de Haan A, Westra J, Kallenberg CG, Bijl M., Clin. Immunol. 136(2), 2010
PMID: 20421178
Influenza virus vaccination and booster in B-cell chronic lymphocytic leukaemia patients.
van der Velden AM, Mulder AH, Hartkamp A, Diepersloot RJ, van Velzen-Blad H, Biesma DH., Eur. J. Intern. Med. 12(5), 2001
PMID: 11557327
Surveying immunogenicity and safety of influenza vaccination in health care workers and HIV-infected individuals.
Vaziri S, Azad TM, Najafi F, Janbakhsh A, Sayyad B., 2009
H1N1 influenza vaccination and infection in pediatric heart transplants.
Vazquez-Alvarez Mdel C, Medrano-Lopez C, Camino-Lopez M., J. Heart Lung Transplant. 29(11), 2010
PMID: 20822923
Influenza vaccination in dialysis and transplant patients.
Versluis DJ, Beyer WE, Masurel N, Weimar W., Antiviral Res. Suppl 1(), 1985
PMID: 3909959
Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine.
Versluis DJ, Beyer WE, Masurel N, Wenting GJ, Weimar W., Transplantation 42(4), 1986
PMID: 3532450
Cyclosporine A impairs the humoral immune response after influenza vaccination in renal transplant recipients.
Versluis DJ, Wenting GJ, Beyer WEP., 1986
Immunization with both T cell-dependent and T cell-independent vaccines augments HIV viral load secondarily to stimulation of tumor necrosis factor alpha.
Vigano A, Bricalli D, Trabattoni D, Salvaggio A, Ruzzante S, Barbi M, Di Sanzo G, Principi N, Clerici M., AIDS Res. Hum. Retroviruses 14(9), 1998
PMID: 9643372
Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy.
Vigano A, Zuccotti GV, Pacei M, Erba P, Castelletti E, Giacomet V, Amendola A, Pariani E, Tanzi E, Clerici M., J. Acquir. Immune Defic. Syndr. 48(3), 2008
PMID: 18545155
Safety and immunogenicity of cold-adapted, live attenuated, influenza vaccine, trivalent (LAIV) in HIV-infected children.
Weinberg GA, King JC, Zangwill K, Fast PE, Wolff M., 2001
Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety.
Wiesik-Szewczyk E, Romanowska M, Mielnik P, Chwalinska-Sadowska H, Brydak LB, Olesinska M, Zabek J., Clin. Rheumatol. 29(6), 2010
PMID: 20140692
The effect of sirolimus therapy on vaccine responses in transplant recipients.
Willcocks LC, Chaudhry AN, Smith JC, Ojha S, Doffinger R, Watson CJ, Smith KG., Am. J. Transplant. 7(8), 2007
PMID: 17578505
Swine influenza vaccination in transplant and dialysis patients.
Winer RL, Ellis MH, Cesario TC, Mirahmadi KS, Tilles JG., 1978
Study on efficacy of influenza vaccination in renal allograft recipients.
Wyzgal J, Brydak LB, Zygier D, Paczek L, Rowinski W, Grochowiecki T., Transplant. Proc. 34(2), 2002
PMID: 12009628
A prospective study of the immunogenicity of inactivated influenza A (H1N1) 2009 monovalent vaccine in patients who have solid or hematologic malignancies.
Xu Y, Methuku N, Coimbatore P, Fitzgerald T, Huang Y., 2009
Serological response to influenza vaccine haematopoetic stem cell transplantation patients.
Yalcin S, Kondolot M, Albayrak N, Altas B, Karacan Y., 2010
Serological response to influenza vaccine after hematopoetic stem cell transplantation.
Yalcin SS, Kondolot M, Albayrak N, Altas AB, Karacan Y, Kuskonmaz B, Aksu S, Cetin M, Goker H, Yurdakok K, Uckan D., Ann. Hematol. 89(9), 2010
PMID: 20119669
Trial of split-product trivalent influenza vaccine in high-risk children.
Yamada A, Yamawaki H, Tsuda N, Baba K, Yabuuchi H, Maeda A, Yamanishi K., Biken J 25(2), 1982
PMID: 6753829
Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients.
Yamanaka H, Teruya K, Tanaka M, Kikuchi Y, Takahashi T, Kimura S, Oka S; HIV/Influenza Vaccine Study Team., J. Acquir. Immune Defic. Syndr. 39(2), 2005
PMID: 15905732
Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load.
Yerly S, Wunderli W, Wyler CA, Kaiser L, Hirschel B, Suter S, Perrin LH, Siegrist CA., AIDS 8(10), 1994
PMID: 7818826
Immunogenicity and tolerability of a trivalent virosomal influenza vaccine in a cohort of HIV-infected children.
Zuccotti GV, Zenga A, Durando P, Massone L, Bruzzone B, Sala D, Riva E., J. Int. Med. Res. 32(5), 2004
PMID: 15458281
Influenza virus vaccination of patients with pulmonary tuberculosis.
Zykov MP, Rafaelskaya TI, Volkon VM, Knoring BE, Shenderova RI., 1980
Vaccination against influenza in patients with pulmonary tuberculosis in tuberculosis dispensaries.
Zykov MP, Subbotina TI, Vishnevsky BI, Shenderova RI, Knoring BE., 1983
Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City.
Fine AD, Bridges CB, De Guzman AM, Glover L, Zeller B, Wong SJ, Baker I, Regnery H, Fukuda K., Clin. Infect. Dis. 32(12), 2001
PMID: 11360221

AUTHOR UNKNOWN, 2007
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M., Lancet 375(9720), 2010
PMID: 20096450
Correlates of protection.
Montomoli E., 2008
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ; Centers for Disease Control and Prevention (CDC)., MMWR Recomm Rep 59(RR-8), 2010
PMID: 20689501
The uptake of influenza and pneumococcal vaccination among immunocompromised patients attending rheumatology outpatient clinics.
Haroon M, Adeeb F, Eltahir A, Harney S., 2010

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 22216224
PubMed | Europe PMC

Suchen in

Google Scholar